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Implementation of dendritic cell- (DC-) based therapies in organ transplantation can reduce dependency on nonspeciﬁc
immunosuppression. Despite extensive research, mechanisms of equipped DCs inducing transplant tolerance remain incomplete.
Here, we applied RNA interference technique to inhibit CD80 and CD86 expression in host bone marrow-derived DCs. This
approach could speciﬁcally and eﬀectively knock down CD80 and CD86 expression. T cells primed by these DCs inhibited
allogeneic responses. Administration of recipient DCs loaded with alloantigen after CD80 and CD86 blockade prolonged cardiac
allograft survival. We also found a higher percentage of apoptotic T cells in lymph tissues and grafts than that detected in control
group. In addition, these T cells expressed high expression of GRP78 than controls, indicating activation of unfolded protein
responses. Upregulation of CHOP expression among these cells suggested that the endoplasmic reticulum stress (ERS) response
switched to a proapoptotic response. Our results indicated that ERS-induced apoptosis may be involved in allogeneic T-cell
apoptosis, and the ERS-mediated apoptosis pathway may be a novel target in clinical prevention and therapy of allograft rejection.
1.Introduction
Dendritic cells (DCs) have been found to be the pivotal
antigen presenting cells (APCs) in regulation of immune
response [1]. Activation through the T cell receptor in the
absence of costimulation is proposed to render responder
T cells anergic or tolerant [2]. The costimulatory signal
is delivered through interactions between the T cells and
APCs and results from ligation of molecules such as CD28
and CD154 (CD40L), expressed on the T cells with their
ligands CD80/CD86 and CD40 respectively, on APCs. Co-
stimulation blockade targeting CD80/CD86 on DCs eﬃ-
ciently prevents acute heart or kidney rejection in many
mouse and rat models [3–7]. First clinical trial has been
conductedto assessco-stimulation blockade strategyin renal
transplantation[8].Itmayallowpatientstoavoidtheadverse
eﬀects of calcineurin inhibitors, whilst providing equally
eﬀective immunosuppression.
Therearedirectandindirectpathwaysofallorecognition,
and both of which have been postulated to have roles in
allograft immunity [9]. Direct alloantigen (Ag) presentation,
mediated by donor APCs, leads to vigorous T cell prolif-
eration and is mainly involved in acute rejection [10]. As
donor DCs undergo attrition, their role as presenters of
alloAg subsides. Then recipient DCs that can inﬁltrate to
the graft become the predominant APCs, and they present
alloAg indirectly to T cells. This indirect pathway is closely
relatedtochronicrejection[11].However,moredatashowed
that indirect recognition might play a more important role
in whole allograft rejection [12–14] and indirect recognition
also can initiate rapid skin graft rejection [15]. In addition,
DCs cannot be obtained from deceased donors; so recipient
DCs would potentially be taken into account in clinical
transplantation.
RNA interference (RNAi) is a recently identiﬁed phe-
nomenoninwhichsmallinterferenceRNA(siRNA)interacts2 Journal of Biomedicine and Biotechnology
Table 1: Sequences of shRNA fragment for inserting lentivirus vector.
Name 5  Sense Loop Antisense 3 
CD80 forward t aaggaaagaggaacgtatgaa ttcaagaga ttcatacgttcctctttcctt ttttttc
CD80 reverse tcgagaaaaaa aaggaaagaggaacgtatgaa tctcttgaa ttcatacgttcctctttcctt a
CD86 forward t gcacagagaaacttgatagtgt ttcaagaga acactatcaagtttctctgtgc ttttttc
CD86 reverse tcgagaaaaaa gcacagagaaacttgatagtgt tctcttgaa acactatcaagtttctctgtgc a
Scrambled forward t ttctccgaacgtgtcacgt ttcaagaga acgtgacacgttcggagaa ttttttc
Scrambled reverse tcgagaaaaaa ttctccgaacgtgtcacgt tctcttgaa acgtgacacgttcggagaa a
T h eb o l dc h a r a c t e r sr e p r e s e n tt h el o o ps e q u e n c e sa n dt h eitalic characters represent the terminator sequences.
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Figure 1: (a) Schematic presentation of the plasmid pGCL-GFP, which encodes an HIV-derived lentiviral vector containing a multiple
cloning site (MCS) for insertion of shRNA constructs to be driven by an upstream U6 promoter and a downstream cytomegalovirus
promoter-GFP ﬂuorescent protein (marker gene) cassette ﬂanked by loxp sites. (b) The stem-loop-encoded shRNA has sequence identity to
a 21-nt region of CD80 mRNA.
with mRNA containing homologous sequences, and ulti-
mately this interaction results in degradation of the target
mRNA. Hill et al. [16] reported that transfection of DCs
with siRNA speciﬁc for IL-12 p35 gene resulted in potent
suppression of gene expression and blockade of bioactive
IL-12 p70 production. This demonstrates that RNAi is a
potential and useful tool to modulate DCs. Based on the
attractive methodology of RNAi for silencing a particular
gene expression, we used lentivirus mediated RNAi to
suppress CD80 and CD86 expression on host DCs.
Endoplasmic reticulum is the organelle in which newly
synthesized secretory and transmembrane proteins form
their proper tertiary structure by posttranslational modi-
ﬁcation, folding, and oligomerization. However, many of
these proteins are unfolded or misfolded by extracellular or
intracellularstimuli.Theaccumulationofmisfoldedproteins
constitutes a risk for living cells. Eukaryotic cells possess
severalmechanisms to adapt to endoplasmic reticulum stress
(ERS) and thereby survive. If the cells are exposed to
prolongedorstrongERS,thecellsaredestroyedbyapoptosis.
Recent evidence indicates that ERS signaling pathways play
an important role in the pathogenesis of neurodegenerative
disordersanddiabetes[17].IncreasingevidencessuggestERS
is involved in allograft injury [18].
At present, it is not known whether ERS is involved
in peripheral tolerance. In this study, we detected that
these DCs-pulsed alloAg could elicit lower proliferative
responses and prolong heart allograft survival. Meanwhile,
we characterized T cell apoptosis in vivo. For the ﬁrst
time, our study demonstrates that ERS-mediated apoptosis
signal pathway is involved in T cell apoptosis after indirect
recognition pathway blockade.
2.MaterialsandMethods
2.1. Animals. C3H/HeJ (C3H; H-2Kk), C57BL/6 (B6; H-
2Kb), and BALB/c (H-2Kd)m i c ew e r ep u r c h a s e df r o m
Shanghai Laboratory Animal Center of Chinese Academy
of Sciences (Shanghai, China) and were maintained in
pathogen-freefacilityatFudanUniversity(Shanghai,China).
Animals were fed with standard chow ad libitum and were
used at 7–9 weeks of age. The animal experimental protocols
were in accordance with Chinese Administration Rule of
Laboratory Animal.Journal of Biomedicine and Biotechnology 3
Table 2: Sequences of primers.
Gene name Forward Reverse
Fas ATGCATGACAGCATCCAAGA TGCTGGCAAAGAGAACACAC
FasL GCAGAAGGAACTGGCAGAAC GCTGGTTGTTGCAAGACTGA
Bax TTGCTGATGGCAACTTCAAC CTCAGCCCATCTTCTTCCAG
Bcl-xL GGTGAGTCGGATTGCAAGTT TGTCTGGTCACTTCCGACTG
GRP78 ACCTGGGTGGGGAAGACTTT TCTTCAAATTTGGCCCGAGT
CHOP TATCTCATCCCCAGGAAACG CTGCTCCTTCTCCTTCATGC
β-action GAAACAGCTTCAGCCCAAA ACGTCAGGTGACTGCTGAA
2.2. Generation of Bone Marrow-Derived DCs. The BM-
derived myeloid DCs were propagated as described [19].
Brieﬂy, the BM cells were removed from femurs and tibias of
C3H mice and depleted of erythrocytes by hypotonic lysis.
The cells were cultured in 24-well plates (1×106/well) in
1mL RPMI 1640 (Gibco, Gaithersburg, MD) supplemented
with 10%v/v fetal bovine serum (FBS) and 10ng/mL
recombinant GM-CSF (R&D Systems, Minneapolis, MN).
All cultures were incubated at 37◦C in 5% humidiﬁed CO2.
Nonadherent granulocytes were removed after 48 hours of
culture. Half media exchange was performed once every 48
hours. After 6 days of culture, 1μg/mL LPS (Sigma, St. Louis,
MO) was added to the culture for 18 hours to allow for
maturation. The purity of DC preparations was routinely
monitored by ﬂow cytometric analysis using anti-CD11c
monoclonal antibody (mAb) (eBioscience, San Diego, CA).
This DC preparation protocol could enrich CD11c+ cells
more than 85%.
2.3. Production of Recombinant Lentivirus. The recombinant
lentivirus was constructed as previously described [20], with
some modiﬁcations. In brief, short hairpin RNA (shRNA)
fragments (Table 1) were hybridized with synthesized sense
andantisenseoligonucleotides.ThehybridizedCD80shRNA
fragment was cloned into the plasmid pGCL-GFP (Figure 1).
Recombinantlentiviruseswereproducedbythetransduction
of 293T cells. The 293T cells were cotransduced with
20μg of pGCL-GFP, 15μg of pHelper1.0, and 10μgo f
pHelper2.0 by 100μL of Lipofectamine 2000 (Invitrogen,
Garlsbad, CA). This recombinant lentivirus was designated
CD80 lenti.T h et i t e r so fCD80 lenti were determined with
a green ﬂuorescent protein (GFP) assay. CD86 lenti and
NC lenti were constructed by a similar process. NC lenti
contained scrambled shRNA fragment, an irrelevant shRNA
with random nucleotides, and a GC ratio close to above-
mentioned shRNA.
2.4. Recombinant Lentivirus Transduction in DCs. Lentivirus
transduction was conducted when DCs were 30%–50%
conﬂuent, lentivirus was added at diﬀerent MOIs in serum-
free medium at 37◦C in 5% humidiﬁed CO2.A f t e r4h o u r s ,
complete medium was added to the cells, and there was
complete replacement of medium after 48 hours. Then,
4 days post transduction, marker gene expression was
examined using ﬂuorescent microscopy.
2.5. Ag Uptake. On day 6 of DCs culture, allogeneic spleno-
cyte lysates were added to the culture at a DC: splenocyte
equivalent ratio of 1:10 for 18 hours at 37◦Ci n5 %
humidiﬁed CO2. B6 splenocyte lysates were obtained by six
cycles of freeze/thaw exposure in PBS.
2.6. Isolation of Graft-Inﬁltrating Lymphocytes. Grafts were
harvested, minced, and homogenized with 5% collagenase
typeII(Worthington,Lakewood,NJ)for30minutesat37◦C.
Tissue debris was removed by 100μm cell strainer. Lym-
phocytes were puriﬁed by lymphocyte separation medium
(Mediatech, Herndon, VA) and then subjected to ﬂow
cytometry.
2.7. Flow Cytometric Analysis. Expression of cell surface Ag
was detected on a FACScan (BD Biosciences, San Jose, CA)
and analyzed using CellQuest software (BD Biosciences).
Cells were stained with the following mAb: PE-IAk, PE-
CD40, PE-CD80, PE-CD86 (eBioscience), and FITC-CD3
(BD Biosciences). Isotype-matched irrelevant mAbs were
used as negative controls. Apoptosis was assessed by PE-
Annexin V staining (BD Biosciences).
2.8. Primary and Secondary Mixed Lymphocyte Reaction
(MLR). For primary MLR, nylon wool-eluted spleen T
cells (2×105) from C3H mice were used as responders. γ-
irradiated (20Gy) DCs derived from C3H BM were used
as stimulators. For secondary MLR, 3 × 106 DCs were
injected into C3H mice. Animals were sacriﬁced 7 days after
injection. Isolated splenic T cells from DCs-injected C3H
mice were responders and restimulated with γ-irradiated B6,
C3H, BALB/c Ag-pulsed C3H-derived DCs. Cultures were
maintained in complete medium for 3 days at 37◦Ci n5 %
humidiﬁed CO2.[ 3H]-TdR (0.5μCi/well) was added for the
ﬁnal 18 hours of culture. Cells were harvested onto glass
ﬁber disks using an automated system, and incorporation
of [3H]-TdR into DNA was assessed by Wallac 1450 liquid
scintillation counter (PerkinElmer, Boston, MA). Results
w e r ee x p r e s s e da sm e a nc o u n t sp e rm i n u t e( c p m )± 1SD.
2.9. Heterotopic Heart Transplantation. Cervical vascularized
heart transplantation was performed from B6 donors to
size-matched C3H recipients using a cuﬀ technique. Graft
survival was assessed by daily palpation. The operation4 Journal of Biomedicine and Biotechnology
was successful when grafts continued to beat for more
than 3 days. Rejection was deﬁned as total cessation of
cardiac contraction. To assess the eﬀect of equipped DCs on
allograft survival, animals received 2×106 cells administered
intravenously through the lateral tail vein 7 days prior to
heart transplantation in the absence of immunosuppression.
2.10. Semiquantitative RT-PCR. Total RNA of splenic T
cells was extracted using Trizol reagent according to the
manufacturer’s instructions (Invitrogen). RNA was then
reverse-transcribed into cDNA, using random primers and
Superscript II reverse transcriptase (Invitrogen). For semi-
quantitative RT-PCR, the PCR ampliﬁcation was performed
using Taq DNA polymerase (Invitrogen). PCR products were
analyzed on agarose gels stained with ethidium bromide and
photographed. The primers of each target gene were shown
in Table 2.
2.11. Statistical Analysis. Statistical analysis was performed
with Stata 8.0 software (Stata, College Station, TX). The data
was given as mean ± 1SD. Statistical comparisons between
groupswerepreformedusingaone-wayANOVAfollowedby
aS c h e ﬀ’s test, as appropriate. Graft survival between groups
oftransplantedanimalswascomparedusingthelog-ranktest
for comparison of survival curves. Values of P<. 05 were
considered statistically signiﬁcant.
3. Results
3.1. Lentivirus Mediates Eﬃc i e n tR N A ii nD C s . To determine
the lentiviral transduction eﬃciency in DCs, GFP expression
was examined by microscopy and ﬂow cytometry at diﬀerent
MOIs on day 4 after transduction. Lentivirus demonstrated
a high (79.8%±5.0%) transduction eﬃciency in DCs at
MOI of 20 (Figure 2). The percentage of GFP-expressing
cells remained minor changes when MOI is >20. Therefore,
in the following experiments all viral titers were at MOI
of 20. To blockade both CD80 and CD86 expression, DCs
were transduced with both CD80 lenti and CD86 lenti.
DCs were collected after LPS stimulation. As measured by
ﬂow cytometry, we found that CD80 lenti and CD86 lenti
together could enhance suppressive eﬀect on CD80 and
CD86 expression (Figure 3(a)). After the activation of LPS,
untreated DCs underwent marked maturation progress. But
as to those transduced DCs LPS failed to bring great changes
of the CD80 and CD86 expression. On the other hand, CD80
lenti and CD86 lenti had no eﬀect on expression of unrelated
proteins (such as MHC-II and CD40) (Figure 3(b)). Our
study indicates that recombinant lentivirus can provide
highly eﬃcient and speciﬁc CD80 and CD86 knockdown in
DCs.
3.2.DCsafterCD80andCD86BlockadeInducesTCellSpeciﬁc
Hyporesponsiveness. To explore the inﬂuence of these DCs
on T cell response, DCs were transduced with recombinant
lentivirus.AfterpulsingB6splenocytelysates,DCswereused
as stimulators of na¨ ıve C3H splenic T cells. CD80 lenti and
CD86 lenti-transduced DCs were poor stimulators of T cells
AB
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Figure 2: Transduction eﬃciency was estimated 4 days after
transduction at indicated MOIs. (a) GFP expression was observed
under light microscopy (top) or ﬂuorescence microscopy (bottom).
(A)MOIof5(×100).(B)MOIof20(×100).DCssawanincreasein
expression of GFP that peaked when MOI = 20. (b) The eﬃciency
of infection was determined by assaying GFP expression by ﬂow
cytometry (green line) and comparing with uninfected control cells
(grey peak).
compared to NC lenti-transduced DCs or no treated DCs
(Figure 4(a)). Next, these DCs were injected into C3H mice
through the lateral tail vein. As shown in Figure 4(b),Tc e l l s
from C3H mice primed by injection of CD80 lenti and CD86
lenti-transduced DCs exhibited marked reduced responses
to alloAg (B6) versus to third party unrelated Ag (BALB/c)
pulsedC3H-derivedDCs.Incontrast,TcellsfromC3Hmice
primed by injection of NC lenti-transduced or no treated
DCs exhibited markedly increased proliferative responsesJournal of Biomedicine and Biotechnology 5
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Figure 3: DCs were transduced with nothing (No treated), CD80 lenti, CD86 lenti, NC lenti,o rb o t hCD80 lenti and CD86 lenti.( a )A f t e r
6 days of culture, the cells were then incubated with LPS (1μg/mL) for 18 hours. Expression of CD80 and CD86 was determined by ﬂow
cytometry. The data show the eﬀect of recombinant lentivirus on inhibition of target molecule expression. Values expressed as mean ± 1SD
from three independent experiments; ∗P<. 05 compared to NC lenti/No treated; ∗∗P<. 05 compared to CD80 lenti; ∗∗∗P<. 05 compared
to CD86 lenti. (b) C3H BM-derived DCs were cultured over 6 days. DCs were stimulated or unstimulated with LPS (1μg/mL) for 18 hours.
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Figure 5: AlloAg-pulsed DCs in NC lenti group, or CD80 lenti and
CD86 lenti group, and third party Ag-pulsed DCs in CD80 lenti and
CD86 lenti group were injected into C3H mice, 7 days before the
transplantation with B6 heart grafts. ∗P<. 05 compared to other
groups.
to donor alloAg and third party Ag-pulsed C3H-derived
DCs. However, T cells from C3H mice primed by injection
of various DCs all exhibited signiﬁcant low proliferative
response to syngeneic Ag (C3H) pulsed DCs.
3.3. DCs after CD80 and CD86 Blockade Prolongs Heart
Allograft Survival. To investigate the therapeutic potential
of these equipped DCs in murine cardiac transplant model,
recipient mice (C3H) were pretreated with 2×106 DCsinNC
lentigroup,orCD80lentiandCD86lentigroup,7daysbefore
heterotopic heart transplantation from B6 to C3H. Control
group was pretreated with PBS. Median survival time (MST)
in the control group was 9.3 days, while NC lenti-transduced
DCs pretreatment accelerated heart allograft rejection (MST
6 days compared to control group). Pretreatment with CD80
lenti and CD86 lenti-transduced DCs signiﬁcantly prolonged
the MST to 21.8 days but had no eﬀect on pulsing third party
Ag (MST 7.5 days). These ﬁndings suggest that infusion of
CD80 lenti and CD86 lenti-transduced DCs-pulsed alloAg
prior to transplantation prolongs heart allograft survival,
and the prolongation is Ag speciﬁc (Figure 5).
3.4. CD80 Lenti and CD86 Lenti-Transduced DCs Increase T
Cell Apoptosis. The most striking ﬁnding from the current
study was the possible mechanism of equipped DCs pro-
longing graft survival. Animals were sacriﬁced 5 days after
transplantation. Lymphocytes were isolated from spleens,
mesenteric lymph nodes, and grafts and were assessed
by Annexin V staining. Apoptotic cell in CD3+ T cell
population from mice receiving CD80 lenti and CD86 lenti-
transduced DCs was markedly higher than the T cells in NC
lenti group (Figure 6).
3.5. ERS-Mediated Apoptosis Pathway Is Involved in Allogeneic
T-Cell Apoptosis. To better characterize the mechanism of
T cell apoptosis after costimulatory blockade, we used RT-
PCR to analyze a number of apoptosis signaling pathway
molecules in recipient spleens. As shown in Figure 7, a strik-
ing upregulation of Bax and GRP78 was found in recipients
treated with CD80 lenti and CD86 lenti-transduced DCs
comparedtoNClenti-transducedDCsorPBS.Thesechanges
in endoplasmic reticulum and mitochondrial pathway were
enhanced by upregulation of CHOP and suppression of Bcl-
xL expression in these cells. But there were no remarkable
changes in death receptor pathway among three groups.
4. Discussion
The success of organ transplantation depends on the
continuous administration of nonspeciﬁc immunosuppres-
sive agents, immunosuppression therapies present risks
for opportunistic infection, malignancy, and a variety of
agent side eﬀects [21]. Progress has recently been made in
dissecting the APC and T cell interactions. In particular,
several DC-based therapies in blocking the costimulation
pathways have achieved encouraging results [3–8]. However,
antibodies or fusion proteins have a limited half-life and
require multiple antibody treatments [22]. High cost and
toxicity restrict the application of the antisense technology
[23]. Adenoviruses are eﬃcient transducers but they activate
immune responses [24]. Therefore we now apply RNAi
technique to equipped DCs. Our previous studies have
indicated that chemically synthesized siRNA can speciﬁcally
and eﬀectively knock down CD80 and CD86 gene expression
in BM-derived DCs [25]. Inhibition of short duration poten-
tially limits their use in vivo. Then we choose recombinant
lentiviruses that contain stem-loop constructs encoding
that hairpin RNAs lend to the intracellular generation of
siRNA-like species [26]. Lentivirus can infect noncycling and
postmitotic cells; reverse transcribed DNA sequences can
subsequentlyintegrate intothegenomeoftargetcellsandare
stably expressed at high levels for extended times [27].
Our data clearly demonstrate that lentivirus transduced
DCs induce T cell hyporesponsiveness and T cells primed by
alloAg-pulsed DCs later inhibit allogeneic responses, in an
Ag-speciﬁc manner. The ﬁndings are similar with Taner et al.
[10] who showed that T cells cross-primed by alloAg-pulsed,
rapamycin treated DCs were hyporesponsive to subsequent
challenge. Recently, a third pathway called semi-direct path-
way has been proposed. Recipient DCs can acquire intact
MHC molecules from donor cells or tissues and stimulate
direct antidonor alloimmune responses [28]. One study
by Mandelbrot et al. [29] showed that MHC-II−/−CD4+
recipients could reject CD80−/−CD86−/− cardiac grafts as
rapidlyaswild-typegrafts.Theobservedacutegraftrejection
may have been due to the direct activation of recipient T
cells by recipient APCs after acquiring intact donor MHC8 Journal of Biomedicine and Biotechnology
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Figure 6: Lymphocytes were isolated from recipient spleens, mesenteric lymph nodes, and grafts on day 5 after transplantation treated with
recombinant lentivirus transduced DCs; these cells were double stained with FITC-conjugated anti-CD3 and PE-conjugated Annexin V,
analyzed by ﬂow cytometry. Numbers indicate the percentage of Annexin V positive cells in CD3+ cell population.
molecules. These showed that recipient DCs appeared to be
a key driver of graft dysfunction. The induction of transplant
tolerance has therefore to focus on these cells.
The CD80/CD86-CD28 pathway is probably the most
important and best characterized in T cell activation [30];
we have shown herein that blockade of CD80 and CD86
by lentivirus mediated RNAi increases cardiac allograft
survival but does not extend it indeﬁnitely. This result
indicates that other costimulatory pathways may regulate
allogeneic immune responses. Since co-stimulation blockade
is less eﬀective in memory T cells than in naive T cells
[31], memory T cells may also play an active role. There
are additional factors to deliberate in DC immunotherapy.
Several groups have addressed whether one or multiple
injections will achieve a more signiﬁcant eﬀect. Further, the
optimal number of DCs to be injected needs to be addressed.
Also, the DCs timing strategies will have to be considered.
The mechanism by which lentivirus transduced DCs
prolong heart allograft survival remains to be determined.
The key requirement for long-term survival is that none
of the activated eﬀector T cells survives in a functional
state [32]. There are three distinct pathways of T cell
apoptosis, which may be interconnected. These include
death receptor pathway, mitochondrial pathway and most
recently described the endoplasmic reticulum pathway [33].
The ﬁrst pathway occurs in repetitively stimulated T cells
and is largely mediated through Fas and through related
members of the TNF-receptor family. The second pathway
occurs when activated T cells are deprived of growth factors.
Bcl-2 family proteins control the release of cytochrome c
andapoptosis-inducingfactorfrommitochondria[34].Sen’s
group has found that alloreactive T cell apoptosis is induced
via Fas/FasL pathway in cardiac allograft [35, 36]. Wekerle
et al. [37] showed that the peripheral deletion of donor-
reactive T cells in the early period after BM transplantation
withcostimulatoryblockadeusinganti-CD154andCTLA4Ig
was mediated in part by Fas and could be overcome by
the constitutive expression of Bcl-xL. Under ERS, unfolded
proteins accumulate in the lumen of the endoplasmic retic-
ulum, and then cells activate a self-protective mechanism
by activation of genes encoding endoplasmic reticulum-
resident chaperones such as BiP/GRP78 and GRP94. If
these adaptive responses are not suﬃcient to relieve cells
from ERS, cells undergo apoptosis associated with several
molecules, including CHOP, caspase-12, and MAP kinase
cascade [38]. Several investigators have reported that ERS
is involved in B cell diﬀerentiation and the innate immune
response [39]. ERS response inﬂuences ischemia-reperfusion
in human liver transplantation [40], while the endoplasmic
reticulum pathway-mediated apoptosis in T cells of the
immune system has not been studied. First we observed
that, in recipient spleens, GRP78 and CHOP were much
higher in recombinant lentivirus group. Furthermore, T cells
induced to undergo apoptosis can release IL-10 as they die.
Phagocytosis of apoptotic cells by macrophages often leads
to the production of IL-10 and TGF and may promoteJournal of Biomedicine and Biotechnology 9
123
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Figure 7: T cells isolated on day 5 after translation from the spleens
of C3H recipients bearing B6 heart allografts treated with PBS or
recombinant lentivirus transduced DCs were used for analysis of T
cell apoptosis signaling pathway molecules by RT-PCR. All data are
representative of three separate experiments.
tolerance [34]. Nevertheless, it is conceivable that apoptosis
of activated T cells not only reduces the mass of T cells but
also promotes active immune regulation that is essential for
long-lasting tolerance.
In summary, RNAi-treated, alloAg-pulsed host DCs can
induce Ag-speciﬁc T cell hyporesponsiveness and prolong
heart allograft survival. Apoptosis of alloreactive T cells is
critical for induction of stable peripheral allograft tolerance.
ERS-mediated apoptosis pathway may play a role in periph-
eral tolerance after heart transplantation with costimulatory
blockade. A detailed understanding of activated T cells
apoptosis in this process will undoubtedly lead to the design
of more eﬀective strategies to achieve tolerance in the clinic.
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